BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
토요일, 9월 12

Hims & Hers Health Inc

HIMSNYSE
Trade with Public
Trade with Public
$27.51
0.070.26%
가까이에: Sep 11, 5:00 PM EST
$27.48
-0.03-0.11%
시간외: 7:58 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

Hims & Hers Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Hims & Hers Health (HIMS).

Price Target Range — 10 Quarters

Analyst Consensus — 14 Analysts

3Buy
11Hold
Consensus RatingHold# Analysts14Avg. Consensus PT$31Upside to Avg. PT+13.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →
DateFirmAnalystActionRating ChangePrice Target
Sep 11, 2026JP MorganCory CarpenterAssumesNeutral$32
Aug 24, 2026Truist SecuritiesJailendra SinghPT RaiseHold$27→$32
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Truist Securities Maintains Hold on Hims & Hers Health, Raises Price Target to $32

Truist Securities analyst Jailendra Singh maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from $27 to $32.
Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Hims & Hers Health, Lowers Price Target to $35

Barclays analyst Glen Santangelo maintains Hims & Hers Health (NYSE:HIMS) with a Overweight and lowers the price target from $39 to $35.
Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Hims & Hers Health, Lowers Price Target to $33

Citigroup analyst Daniel Grosslight maintains Hims & Hers Health (NYSE:HIMS) with a Neutral and lowers the price target from $35 to $33.
Benzinga Newsdesk

PRO
Deutsche Bank Maintains Hold on Hims & Hers Health, Raises Price Target to $26

Deutsche Bank analyst George Hill maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from $25 to $26.
Benzinga Newsdesk

PRO
B of A Securities Maintains Neutral on Hims & Hers Health, Raises Price Target to $32

B of A Securities analyst Allen Lutz maintains Hims & Hers Health (NYSE:HIMS) with a Neutral and raises the price target from $30 to $32.
Benzinga Newsdesk

PRO
TD Cowen Maintains Hold on Hims & Hers Health, Raises Price Target to $30

TD Cowen analyst Jonna Kim maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from $25 to $30.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved